Earlier, the DGDA formulated a guideline on the adverse effects of the Covid-19 vaccine and it was approved by the Health Ministry
The government has formed a divisional level committee to assess adverse events following immunization (AEFI) after the roll out of Covid-19 vaccine in the country.
The Divisional AEFI Causality Assessment Committee includes 14 members, said a letter sent by the Directorate General of Drug Administration (DGDA) to the Directorate General of Health Services (DGHS) on Monday.
The director of the government medical college and hospital will be the committee chairperson at the divisional headquarters and divisional director (health) of DGHS will act as its co-chairperson, it said.
Also Read - Government to fix private vaccine price
Earlier, the DGDA formulated a guideline on the adverse effects of the Covid-19 vaccine and it was approved by the Health Ministry.
In December, the government formed a 15-member committee to assure quality of Covid-19 vaccine.
The health authorities said a nationwide vaccination program would start from the first week of February.
On Monday, Health Minister Zahid Maleque said Serum Institute of India (SII) was expected to export its first lot of the Oxford-AstraZeneca coronavirus vaccine to Bangladesh by January 25-26.